Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
0.8905
+0.0317 (3.69%)
At close: May 12, 2025, 4:00 PM
0.8930
+0.0025 (0.28%)
After-hours: May 12, 2025, 7:10 PM EDT
Clearside Biomedical Employees
Clearside Biomedical had 32 employees as of December 31, 2024. The number of employees increased by 2 or 6.67% compared to the previous year.
Employees
32
Change (1Y)
2
Growth (1Y)
6.67%
Revenue / Employee
$52,000
Profits / Employee
-$1,073,500
Market Cap
68.82M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CLSD News
- 3 days ago - Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting - GlobeNewsWire
- 4 days ago - Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - GlobeNewsWire
- 11 days ago - Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference - GlobeNewsWire
- 5 weeks ago - Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Clearside Biomedical, Inc. (CLSD) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 6 weeks ago - Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting - GlobeNewsWire
- 7 weeks ago - Clearside Biomedical's Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit - GlobeNewsWire